Patients Face New Barriers for GLP-1 Drugs Like Wegovy and Ozempic
Even With Lower Prices, Medicare, Medicaid, and Other Insurers Tighten Coverage for Drugs Like Mounjaro and Zepbound Using Prior Authorization and Other Tools
Even With Lower Prices, Medicare, Medicaid, and Other Insurers Tighten Coverage for Drugs Like Mounjaro and Zepbound Using Prior Authorization and Other Tools
Guidelines Matter, but Lasting Health Requires Investment in Better Food, More Activity, and More Targeted Tools From Medicaid and SNAP
A Wharton–Netter Center Collaboration Uses Experiential Learning to Build a Health Care Workforce Pipeline
Cheaper Housing Could be a Way to Lower Hospitalizations Among Medicaid Patients with Heart Failure
An LDI Expert Connects Nurse Wellbeing and Staffing to Patient Safety Outcomes
Preparing for Challenges Ahead
Issue Brief: Understanding Gaps and Opportunities to Advance Research and Policy
A 2024 Study Showing How Even Small Copays Reduce PrEP Use Fueled Media, Legal, and Advocacy Efforts As Courts Weighed a Case Threatening No-Cost Preventive Care for Millions
The Odd Paradox of the Big Beautiful Bill’s Health Care Goals